HCP is an extremely rare autosomal dominant disorder with incomplete penetrance, caused by deficiency of coproporphyrinogen oxidase (CPOX), an enzyme in the heme pathway.
HCP typically presents after puberty, but pediatric cases have been reported. It is more common in women.
HCP can have both cutaneous and neurovisceral symptoms. Neurovisceral attacks are potentially fatal. The spectrum of presentation is broad. Cutaneous manifestations are seen in 20%-30% of the patients with HCP and are similar to other blistering porphyrias (eg, PCT, hepatoerythropoietic porphyria, and VP), while the neurovisceral attacks are similar to other acute porphyrias (acute intermittent porphyria, ALA dehydratase deficiency porphyria, and VP).
Acute neurovisceral attacks are highly variable from patient to patient and can be characterized by fever, severe pain (eg, chest, abdomen, back, limbs), and gastrointestinal symptoms such as cramping, nausea / vomiting, constipation / abdominal distention, and rarely diarrhea. Cardiovascular effects can be seen with hypertension, tachycardia, and chest pain. Patients can experience psychological symptoms with anxiety, disorientation, agitation, and psychosis. Neurological symptoms include sensory and motor deficits and seizures; motor weakness can lead to respiratory failure, which can be fatal. Urinary retention can result from bladder paresis. Hyponatremia may result from nausea / vomiting and diarrhea or syndrome of inappropriate antidiuretic hormone (SIADH). Respiratory paralysis and cardiac arrhythmia can occur during acute neurovisceral attacks and signal a medical emergency.
Cutaneous findings are similar to other blistering porphyrias with photosensitivity, blisters, dyspigmentation, and scarring on sun-exposed sites (ie, face, neck, dorsal forearms / hands, and feet).
Risk factors for flares include certain drugs, metabolic stress (ie, low carbohydrate intake or sudden drop in weight), smoking, and alcohol use. HCP can flare with the luteal phase of the menstrual cycle.
There is an increased risk of hepatocellular carcinoma in patients with HCP, with ages of diagnosis ranging from 37-65 years of age; thus, routine monitoring is needed, particularly for those with other risk factors including cirrhosis, hepatitis C, or alcohol use disorder.
For more information, see OMIM.
E80.29 – Other porphyria
7425008 – Hereditary Coproporphyria
- Variegate porphyria (VP) – VP is also characterized by cutaneous manifestations and acute neurovisceral attacks; distinguished by biochemical studies.
- Other cutaneous blistering porphyrias – The skin manifestations are similar to porphyria cutanea tarda (PCT) and hepatoerythropoietic porphyria.
- Other acute hepatic porphyrias – Neurovisceral attacks similar to acute intermittent porphyria and ALA dehydratase deficiency porphyria; distinguished by biochemical studies.
- Psychological / psychiatric disorder – See, eg, depression, anxiety, or psychosis.
- Abdominal pain differential includes mesenteric ischemia, gastritis, pancreatitis, large bowel obstruction, and small bowel obstruction.
Last Updated: 03/17/2020